Somrudee Reabroi

Andrographolide Exhibits Anticancer Activity against Breast Cancer Cells (MCF-7 and MDA-MB-231 Cells) through Suppressing Cell Proliferation and Inducing Cell Apoptosis via Inactivation of ER-α Receptor and PI3K/AKT/mTOR Signaling

Ruhainee Tohkayomatee, Somrudee Reabroi, Duangjai Tungmunnithum et al. · Molecules · 2022 · 50 citations · Full text

Medicine, Oncology, Pharmacology +17

Induction of apoptosis in cholangiocarcinoma by an andrographolide analogue is mediated through topoisomerase II alpha inhibition

Jintapat Nateewattana, Suman Dutta, Somrudee Reabroi et al. · European Journal of Pharmacology · 2013 · 35 citations

Medicine, Oncology, Pharmacology +14

The anti-cancer activity of an andrographolide analogue functions through a GSK-3β-independent Wnt/β-catenin signaling pathway in colorectal cancer cells

Somrudee Reabroi, Rungnapha Saeeng, Nittaya Boonmuen et al. · Scientific Reports · 2018 · 34 citations · Full text

Medicine, Oncology, Pharmacology +17

Solubility enhancement and<i>in vitro</i>evaluation of PEG-<i>b</i>-PLA micelles as nanocarrier of semi-synthetic andrographolide analogue for cholangiocarcinoma chemotherapy

Sujittra Puntawee, Man Theerasilp, Somrudee Reabroi et al. · Pharmaceutical Development and Technology · 2015 · 25 citations

Pharmacy, Medicinal Chemistry, Pharmacology +17

A silyl andrographolide analogue suppresses Wnt/β-catenin signaling pathway in colon cancer

Somrudee Reabroi, Arthit Chairoungdua, Rungnapha Saeeng et al. · Biomedicine & Pharmacotherapy · 2018 · 25 citations

Medicine, Cancer Biology, Oncology +14